nodes	percent_of_prediction	percent_of_DWPC	metapath
Levomilnacipran—CYP3A4—Temozolomide—malignant glioma	0.0897	1	CbGbCtD
Levomilnacipran—CYP2J2—blood vessel—malignant glioma	0.0124	0.145	CbGeAlD
Levomilnacipran—Diethylpropion—SLC6A3—malignant glioma	0.0103	0.497	CrCbGaD
Levomilnacipran—Extrapyramidal disorder—Temozolomide—malignant glioma	0.00755	0.0265	CcSEcCtD
Levomilnacipran—Endocrine disorder—Temozolomide—malignant glioma	0.00686	0.0241	CcSEcCtD
Levomilnacipran—CYP2J2—telencephalon—malignant glioma	0.00601	0.0706	CbGeAlD
Levomilnacipran—Pethidine—CYP2B6—malignant glioma	0.00561	0.271	CrCbGaD
Levomilnacipran—Dry eye—Temozolomide—malignant glioma	0.00525	0.0185	CcSEcCtD
Levomilnacipran—Pethidine—SLC6A3—malignant glioma	0.00478	0.231	CrCbGaD
Levomilnacipran—CYP2J2—medulla oblongata—malignant glioma	0.00472	0.0554	CbGeAlD
Levomilnacipran—Hot flush—Temozolomide—malignant glioma	0.00441	0.0155	CcSEcCtD
Levomilnacipran—Menopausal symptoms—Temozolomide—malignant glioma	0.00437	0.0154	CcSEcCtD
Levomilnacipran—Thirst—Temozolomide—malignant glioma	0.00434	0.0152	CcSEcCtD
Levomilnacipran—CYP2J2—midbrain—malignant glioma	0.00432	0.0507	CbGeAlD
Levomilnacipran—Hyponatraemia—Carmustine—malignant glioma	0.00429	0.0151	CcSEcCtD
Levomilnacipran—CYP2J2—spinal cord—malignant glioma	0.00421	0.0494	CbGeAlD
Levomilnacipran—Liver function test abnormal—Carmustine—malignant glioma	0.00394	0.0139	CcSEcCtD
Levomilnacipran—Dry skin—Temozolomide—malignant glioma	0.00378	0.0133	CcSEcCtD
Levomilnacipran—Breast disorder—Temozolomide—malignant glioma	0.00373	0.0131	CcSEcCtD
Levomilnacipran—SLC6A4—brainstem—malignant glioma	0.00365	0.0429	CbGeAlD
Levomilnacipran—Abdominal distension—Temozolomide—malignant glioma	0.00359	0.0126	CcSEcCtD
Levomilnacipran—Neutropenia—Carmustine—malignant glioma	0.00345	0.0121	CcSEcCtD
Levomilnacipran—CYP2J2—central nervous system—malignant glioma	0.00342	0.0401	CbGeAlD
Levomilnacipran—CYP2J2—cerebellum—malignant glioma	0.00334	0.0392	CbGeAlD
Levomilnacipran—Dysuria—Temozolomide—malignant glioma	0.00333	0.0117	CcSEcCtD
Levomilnacipran—Neutropenia—Temozolomide—malignant glioma	0.00333	0.0117	CcSEcCtD
Levomilnacipran—Upper respiratory tract infection—Temozolomide—malignant glioma	0.00331	0.0117	CcSEcCtD
Levomilnacipran—Pollakiuria—Temozolomide—malignant glioma	0.00329	0.0116	CcSEcCtD
Levomilnacipran—Erectile dysfunction—Temozolomide—malignant glioma	0.00328	0.0116	CcSEcCtD
Levomilnacipran—SLC6A4—telencephalon—malignant glioma	0.00324	0.038	CbGeAlD
Levomilnacipran—Weight decreased—Temozolomide—malignant glioma	0.00323	0.0113	CcSEcCtD
Levomilnacipran—SLC6A2—brainstem—malignant glioma	0.00322	0.0377	CbGeAlD
Levomilnacipran—Urinary tract infection—Carmustine—malignant glioma	0.0032	0.0112	CcSEcCtD
Levomilnacipran—Stevens-Johnson syndrome—Temozolomide—malignant glioma	0.00315	0.0111	CcSEcCtD
Levomilnacipran—Urinary tract infection—Temozolomide—malignant glioma	0.00309	0.0109	CcSEcCtD
Levomilnacipran—Hepatobiliary disease—Temozolomide—malignant glioma	0.00301	0.0106	CcSEcCtD
Levomilnacipran—Hallucination—Carmustine—malignant glioma	0.00294	0.0103	CcSEcCtD
Levomilnacipran—Hypoaesthesia—Carmustine—malignant glioma	0.00294	0.0103	CcSEcCtD
Levomilnacipran—Oedema peripheral—Carmustine—malignant glioma	0.00291	0.0102	CcSEcCtD
Levomilnacipran—Connective tissue disorder—Carmustine—malignant glioma	0.0029	0.0102	CcSEcCtD
Levomilnacipran—SLC6A2—telencephalon—malignant glioma	0.00285	0.0335	CbGeAlD
Levomilnacipran—Hepatitis—Temozolomide—malignant glioma	0.00285	0.01	CcSEcCtD
Levomilnacipran—Hallucination—Temozolomide—malignant glioma	0.00284	0.00999	CcSEcCtD
Levomilnacipran—Hypoaesthesia—Temozolomide—malignant glioma	0.00284	0.00999	CcSEcCtD
Levomilnacipran—Urinary tract disorder—Temozolomide—malignant glioma	0.00282	0.00991	CcSEcCtD
Levomilnacipran—Oedema peripheral—Temozolomide—malignant glioma	0.00281	0.00989	CcSEcCtD
Levomilnacipran—Connective tissue disorder—Temozolomide—malignant glioma	0.0028	0.00986	CcSEcCtD
Levomilnacipran—Urethral disorder—Temozolomide—malignant glioma	0.0028	0.00984	CcSEcCtD
Levomilnacipran—Eye disorder—Carmustine—malignant glioma	0.00276	0.00971	CcSEcCtD
Levomilnacipran—Flushing—Carmustine—malignant glioma	0.00274	0.00964	CcSEcCtD
Levomilnacipran—CYP2J2—brain—malignant glioma	0.00271	0.0318	CbGeAlD
Levomilnacipran—Erythema multiforme—Temozolomide—malignant glioma	0.0027	0.00949	CcSEcCtD
Levomilnacipran—Eye disorder—Temozolomide—malignant glioma	0.00267	0.00938	CcSEcCtD
Levomilnacipran—Flushing—Temozolomide—malignant glioma	0.00265	0.00932	CcSEcCtD
Levomilnacipran—Cardiac disorder—Temozolomide—malignant glioma	0.00265	0.00932	CcSEcCtD
Levomilnacipran—Angiopathy—Temozolomide—malignant glioma	0.00259	0.00911	CcSEcCtD
Levomilnacipran—Mental disorder—Carmustine—malignant glioma	0.00259	0.0091	CcSEcCtD
Levomilnacipran—Mediastinal disorder—Temozolomide—malignant glioma	0.00257	0.00905	CcSEcCtD
Levomilnacipran—Malnutrition—Carmustine—malignant glioma	0.00257	0.00904	CcSEcCtD
Levomilnacipran—Chills—Temozolomide—malignant glioma	0.00256	0.00901	CcSEcCtD
Levomilnacipran—Mental disorder—Temozolomide—malignant glioma	0.0025	0.00879	CcSEcCtD
Levomilnacipran—Malnutrition—Temozolomide—malignant glioma	0.00248	0.00874	CcSEcCtD
Levomilnacipran—Dysgeusia—Temozolomide—malignant glioma	0.00243	0.00856	CcSEcCtD
Levomilnacipran—Vision blurred—Carmustine—malignant glioma	0.00242	0.00852	CcSEcCtD
Levomilnacipran—Tremor—Carmustine—malignant glioma	0.00241	0.00847	CcSEcCtD
Levomilnacipran—Agitation—Carmustine—malignant glioma	0.00236	0.00831	CcSEcCtD
Levomilnacipran—Vision blurred—Temozolomide—malignant glioma	0.00234	0.00824	CcSEcCtD
Levomilnacipran—SLC6A4—midbrain—malignant glioma	0.00233	0.0273	CbGeAlD
Levomilnacipran—Tremor—Temozolomide—malignant glioma	0.00233	0.00819	CcSEcCtD
Levomilnacipran—ABCB1—blood vessel—malignant glioma	0.00232	0.0272	CbGeAlD
Levomilnacipran—Leukopenia—Carmustine—malignant glioma	0.0023	0.00809	CcSEcCtD
Levomilnacipran—Agitation—Temozolomide—malignant glioma	0.00228	0.00803	CcSEcCtD
Levomilnacipran—SLC6A4—spinal cord—malignant glioma	0.00227	0.0267	CbGeAlD
Levomilnacipran—SLC6A2—medulla oblongata—malignant glioma	0.00224	0.0263	CbGeAlD
Levomilnacipran—Convulsion—Carmustine—malignant glioma	0.00223	0.00783	CcSEcCtD
Levomilnacipran—Leukopenia—Temozolomide—malignant glioma	0.00222	0.00782	CcSEcCtD
Levomilnacipran—Hypertension—Carmustine—malignant glioma	0.00222	0.00781	CcSEcCtD
Levomilnacipran—Palpitations—Temozolomide—malignant glioma	0.0022	0.00772	CcSEcCtD
Levomilnacipran—Chest pain—Carmustine—malignant glioma	0.00219	0.0077	CcSEcCtD
Levomilnacipran—Anxiety—Carmustine—malignant glioma	0.00218	0.00767	CcSEcCtD
Levomilnacipran—Convulsion—Temozolomide—malignant glioma	0.00215	0.00757	CcSEcCtD
Levomilnacipran—Hypertension—Temozolomide—malignant glioma	0.00215	0.00754	CcSEcCtD
Levomilnacipran—Anxiety—Temozolomide—malignant glioma	0.00211	0.00741	CcSEcCtD
Levomilnacipran—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—malignant glioma	0.0021	0.00739	CcSEcCtD
Levomilnacipran—Infection—Carmustine—malignant glioma	0.00208	0.00733	CcSEcCtD
Levomilnacipran—Dry mouth—Temozolomide—malignant glioma	0.00207	0.00728	CcSEcCtD
Levomilnacipran—Thrombocytopenia—Carmustine—malignant glioma	0.00205	0.00723	CcSEcCtD
Levomilnacipran—Tachycardia—Carmustine—malignant glioma	0.00205	0.0072	CcSEcCtD
Levomilnacipran—Infection—Temozolomide—malignant glioma	0.00201	0.00709	CcSEcCtD
Levomilnacipran—Anorexia—Carmustine—malignant glioma	0.002	0.00703	CcSEcCtD
Levomilnacipran—Nervous system disorder—Temozolomide—malignant glioma	0.00199	0.00699	CcSEcCtD
Levomilnacipran—Thrombocytopenia—Temozolomide—malignant glioma	0.00199	0.00698	CcSEcCtD
Levomilnacipran—Skin disorder—Temozolomide—malignant glioma	0.00197	0.00693	CcSEcCtD
Levomilnacipran—Hypotension—Carmustine—malignant glioma	0.00196	0.0069	CcSEcCtD
Levomilnacipran—Hyperhidrosis—Temozolomide—malignant glioma	0.00196	0.00689	CcSEcCtD
Levomilnacipran—Anorexia—Temozolomide—malignant glioma	0.00193	0.0068	CcSEcCtD
Levomilnacipran—Insomnia—Carmustine—malignant glioma	0.0019	0.00667	CcSEcCtD
Levomilnacipran—Paraesthesia—Carmustine—malignant glioma	0.00188	0.00663	CcSEcCtD
Levomilnacipran—Dyspnoea—Carmustine—malignant glioma	0.00187	0.00658	CcSEcCtD
Levomilnacipran—Somnolence—Carmustine—malignant glioma	0.00187	0.00656	CcSEcCtD
Levomilnacipran—SLC6A4—central nervous system—malignant glioma	0.00184	0.0216	CbGeAlD
Levomilnacipran—Insomnia—Temozolomide—malignant glioma	0.00183	0.00645	CcSEcCtD
Levomilnacipran—Decreased appetite—Carmustine—malignant glioma	0.00182	0.00642	CcSEcCtD
Levomilnacipran—Paraesthesia—Temozolomide—malignant glioma	0.00182	0.0064	CcSEcCtD
Levomilnacipran—Gastrointestinal disorder—Carmustine—malignant glioma	0.00181	0.00637	CcSEcCtD
Levomilnacipran—Dyspnoea—Temozolomide—malignant glioma	0.00181	0.00636	CcSEcCtD
Levomilnacipran—Somnolence—Temozolomide—malignant glioma	0.0018	0.00634	CcSEcCtD
Levomilnacipran—Constipation—Carmustine—malignant glioma	0.00179	0.00631	CcSEcCtD
Levomilnacipran—Dyspepsia—Temozolomide—malignant glioma	0.00178	0.00628	CcSEcCtD
Levomilnacipran—Decreased appetite—Temozolomide—malignant glioma	0.00176	0.0062	CcSEcCtD
Levomilnacipran—CYP2D6—brainstem—malignant glioma	0.00176	0.0207	CbGeAlD
Levomilnacipran—Gastrointestinal disorder—Temozolomide—malignant glioma	0.00175	0.00616	CcSEcCtD
Levomilnacipran—Fatigue—Temozolomide—malignant glioma	0.00175	0.00615	CcSEcCtD
Levomilnacipran—Constipation—Temozolomide—malignant glioma	0.00173	0.0061	CcSEcCtD
Levomilnacipran—Gastrointestinal pain—Carmustine—malignant glioma	0.00172	0.00603	CcSEcCtD
Levomilnacipran—Body temperature increased—Carmustine—malignant glioma	0.00166	0.00583	CcSEcCtD
Levomilnacipran—Abdominal pain—Carmustine—malignant glioma	0.00166	0.00583	CcSEcCtD
Levomilnacipran—Gastrointestinal pain—Temozolomide—malignant glioma	0.00166	0.00583	CcSEcCtD
Levomilnacipran—SLC6A2—central nervous system—malignant glioma	0.00162	0.019	CbGeAlD
Levomilnacipran—Urticaria—Temozolomide—malignant glioma	0.00161	0.00567	CcSEcCtD
Levomilnacipran—Body temperature increased—Temozolomide—malignant glioma	0.0016	0.00564	CcSEcCtD
Levomilnacipran—Abdominal pain—Temozolomide—malignant glioma	0.0016	0.00564	CcSEcCtD
Levomilnacipran—CYP2D6—telencephalon—malignant glioma	0.00156	0.0183	CbGeAlD
Levomilnacipran—Hypersensitivity—Carmustine—malignant glioma	0.00155	0.00544	CcSEcCtD
Levomilnacipran—Asthenia—Carmustine—malignant glioma	0.00151	0.00529	CcSEcCtD
Levomilnacipran—Hypersensitivity—Temozolomide—malignant glioma	0.00149	0.00525	CcSEcCtD
Levomilnacipran—SLC6A4—brain—malignant glioma	0.00146	0.0172	CbGeAlD
Levomilnacipran—Asthenia—Temozolomide—malignant glioma	0.00145	0.00512	CcSEcCtD
Levomilnacipran—Diarrhoea—Carmustine—malignant glioma	0.00144	0.00505	CcSEcCtD
Levomilnacipran—Pruritus—Temozolomide—malignant glioma	0.00143	0.00505	CcSEcCtD
Levomilnacipran—Dizziness—Carmustine—malignant glioma	0.00139	0.00488	CcSEcCtD
Levomilnacipran—Diarrhoea—Temozolomide—malignant glioma	0.00139	0.00488	CcSEcCtD
Levomilnacipran—ABCB1—embryo—malignant glioma	0.00138	0.0162	CbGeAlD
Levomilnacipran—Dizziness—Temozolomide—malignant glioma	0.00134	0.00472	CcSEcCtD
Levomilnacipran—Vomiting—Carmustine—malignant glioma	0.00133	0.00469	CcSEcCtD
Levomilnacipran—Rash—Carmustine—malignant glioma	0.00132	0.00465	CcSEcCtD
Levomilnacipran—Dermatitis—Carmustine—malignant glioma	0.00132	0.00465	CcSEcCtD
Levomilnacipran—Headache—Carmustine—malignant glioma	0.00131	0.00462	CcSEcCtD
Levomilnacipran—Vomiting—Temozolomide—malignant glioma	0.00129	0.00453	CcSEcCtD
Levomilnacipran—SLC6A2—brain—malignant glioma	0.00129	0.0151	CbGeAlD
Levomilnacipran—Rash—Temozolomide—malignant glioma	0.00128	0.0045	CcSEcCtD
Levomilnacipran—Dermatitis—Temozolomide—malignant glioma	0.00128	0.00449	CcSEcCtD
Levomilnacipran—Headache—Temozolomide—malignant glioma	0.00127	0.00447	CcSEcCtD
Levomilnacipran—Nausea—Carmustine—malignant glioma	0.00125	0.00438	CcSEcCtD
Levomilnacipran—ABCB1—retina—malignant glioma	0.00122	0.0143	CbGeAlD
Levomilnacipran—Nausea—Temozolomide—malignant glioma	0.0012	0.00424	CcSEcCtD
Levomilnacipran—ABCB1—telencephalon—malignant glioma	0.00112	0.0132	CbGeAlD
Levomilnacipran—CYP2C8—brain—malignant glioma	0.00106	0.0124	CbGeAlD
Levomilnacipran—CYP3A4—central nervous system—malignant glioma	0.000903	0.0106	CbGeAlD
Levomilnacipran—CYP2D6—central nervous system—malignant glioma	0.000888	0.0104	CbGeAlD
Levomilnacipran—ABCB1—medulla oblongata—malignant glioma	0.000883	0.0104	CbGeAlD
Levomilnacipran—CYP2D6—cerebellum—malignant glioma	0.000868	0.0102	CbGeAlD
Levomilnacipran—ABCB1—midbrain—malignant glioma	0.000807	0.00947	CbGeAlD
Levomilnacipran—ABCB1—spinal cord—malignant glioma	0.000788	0.00924	CbGeAlD
Levomilnacipran—CYP2D6—brain—malignant glioma	0.000705	0.00828	CbGeAlD
Levomilnacipran—ABCB1—central nervous system—malignant glioma	0.000639	0.0075	CbGeAlD
Levomilnacipran—ABCB1—cerebellum—malignant glioma	0.000625	0.00733	CbGeAlD
Levomilnacipran—ABCB1—brain—malignant glioma	0.000507	0.00595	CbGeAlD
Levomilnacipran—CYP2C19—Arachidonic acid metabolism—PTGS2—malignant glioma	0.000403	0.000776	CbGpPWpGaD
Levomilnacipran—CYP2J2—Metabolism—CYP2C18—malignant glioma	0.000397	0.000763	CbGpPWpGaD
Levomilnacipran—CYP2C19—Biological oxidations—PTGS1—malignant glioma	0.000392	0.000753	CbGpPWpGaD
Levomilnacipran—SLC6A4—SIDS Susceptibility Pathways—IL1B—malignant glioma	0.000389	0.000748	CbGpPWpGaD
Levomilnacipran—SLC6A4—SIDS Susceptibility Pathways—CASP3—malignant glioma	0.000388	0.000747	CbGpPWpGaD
Levomilnacipran—CYP2D6—Biological oxidations—GSTT1—malignant glioma	0.000385	0.000739	CbGpPWpGaD
Levomilnacipran—ABCB1—Integrated Pancreatic Cancer Pathway—PML—malignant glioma	0.000384	0.000739	CbGpPWpGaD
Levomilnacipran—CYP2J2—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	0.000374	0.000719	CbGpPWpGaD
Levomilnacipran—CYP2D6—Biological oxidations—PTGS1—malignant glioma	0.00036	0.000693	CbGpPWpGaD
Levomilnacipran—ABCB1—Allograft Rejection—CD80—malignant glioma	0.00036	0.000693	CbGpPWpGaD
Levomilnacipran—CYP3A4—Biological oxidations—CYP2B6—malignant glioma	0.000359	0.000689	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metapathway biotransformation—CYP2B6—malignant glioma	0.000354	0.00068	CbGpPWpGaD
Levomilnacipran—ABCB1—Integrated Pancreatic Cancer Pathway—TOP2A—malignant glioma	0.000352	0.000676	CbGpPWpGaD
Levomilnacipran—ABCB1—Transmembrane transport of small molecules—COX8A—malignant glioma	0.000351	0.000674	CbGpPWpGaD
Levomilnacipran—CYP2J2—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	0.000341	0.000655	CbGpPWpGaD
Levomilnacipran—SLC6A4—SIDS Susceptibility Pathways—VEGFA—malignant glioma	0.00033	0.000634	CbGpPWpGaD
Levomilnacipran—CYP2J2—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	0.000329	0.000632	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—RTEL1—malignant glioma	0.000328	0.000631	CbGpPWpGaD
Levomilnacipran—CYP2C8—Biological oxidations—GSTP1—malignant glioma	0.000325	0.000624	CbGpPWpGaD
Levomilnacipran—CYP2J2—Metabolism—GSTT1—malignant glioma	0.000321	0.000617	CbGpPWpGaD
Levomilnacipran—ABCB1—Transmembrane transport of small molecules—FTH1—malignant glioma	0.000321	0.000617	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metapathway biotransformation—GSTP1—malignant glioma	0.00032	0.000616	CbGpPWpGaD
Levomilnacipran—SLC6A2—Transmembrane transport of small molecules—TFRC—malignant glioma	0.000317	0.00061	CbGpPWpGaD
Levomilnacipran—CYP3A4—Biological oxidations—CYP2C18—malignant glioma	0.000311	0.000598	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metapathway biotransformation—CYP2C18—malignant glioma	0.000307	0.00059	CbGpPWpGaD
Levomilnacipran—CYP2J2—Metabolism—PTGS1—malignant glioma	0.000301	0.000578	CbGpPWpGaD
Levomilnacipran—CYP2J2—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	0.0003	0.000576	CbGpPWpGaD
Levomilnacipran—SLC6A4—Circadian rythm related genes—PTEN—malignant glioma	0.000298	0.000573	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—RTEL1—malignant glioma	0.000293	0.000563	CbGpPWpGaD
Levomilnacipran—SLC6A2—Transmembrane transport of small molecules—SLC5A5—malignant glioma	0.000291	0.00056	CbGpPWpGaD
Levomilnacipran—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—malignant glioma	0.00029	0.000558	CbGpPWpGaD
Levomilnacipran—CYP2C19—Biological oxidations—GSTP1—malignant glioma	0.00029	0.000557	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—RTEL1—malignant glioma	0.000286	0.00055	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metapathway biotransformation—GSTP1—malignant glioma	0.000286	0.00055	CbGpPWpGaD
Levomilnacipran—ABCB1—Allograft Rejection—IFNG—malignant glioma	0.000285	0.000548	CbGpPWpGaD
Levomilnacipran—SLC6A4—SIDS Susceptibility Pathways—TNF—malignant glioma	0.000282	0.000543	CbGpPWpGaD
Levomilnacipran—ABCB1—Transmembrane transport of small molecules—ATP1B2—malignant glioma	0.00028	0.000539	CbGpPWpGaD
Levomilnacipran—CYP2J2—Metabolism—BCHE—malignant glioma	0.00028	0.000537	CbGpPWpGaD
Levomilnacipran—SLC6A2—Transmembrane transport of small molecules—SLC6A3—malignant glioma	0.000277	0.000533	CbGpPWpGaD
Levomilnacipran—CYP2J2—Metabolism—SLC5A5—malignant glioma	0.000276	0.000531	CbGpPWpGaD
Levomilnacipran—ABCB1—Integrated Pancreatic Cancer Pathway—NTRK1—malignant glioma	0.000273	0.000526	CbGpPWpGaD
Levomilnacipran—ABCB1—Transmembrane transport of small molecules—APOD—malignant glioma	0.000273	0.000524	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—RTEL1—malignant glioma	0.000269	0.000518	CbGpPWpGaD
Levomilnacipran—CYP3A4—Tryptophan metabolism—MDM2—malignant glioma	0.000269	0.000517	CbGpPWpGaD
Levomilnacipran—CYP2D6—Biological oxidations—GSTP1—malignant glioma	0.000267	0.000512	CbGpPWpGaD
Levomilnacipran—ABCB1—Allograft Rejection—CXCL8—malignant glioma	0.000265	0.000509	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metapathway biotransformation—GSTP1—malignant glioma	0.000263	0.000505	CbGpPWpGaD
Levomilnacipran—CYP2J2—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	0.000261	0.000502	CbGpPWpGaD
Levomilnacipran—CYP2J2—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	0.000259	0.000497	CbGpPWpGaD
Levomilnacipran—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—malignant glioma	0.000254	0.000489	CbGpPWpGaD
Levomilnacipran—ABCB1—Allograft Rejection—IL1B—malignant glioma	0.000254	0.000488	CbGpPWpGaD
Levomilnacipran—ABCB1—Allograft Rejection—CASP3—malignant glioma	0.000253	0.000487	CbGpPWpGaD
Levomilnacipran—ABCB1—Allograft Rejection—IL2—malignant glioma	0.000253	0.000487	CbGpPWpGaD
Levomilnacipran—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN2B—malignant glioma	0.000252	0.000485	CbGpPWpGaD
Levomilnacipran—CYP3A4—Biological oxidations—GSTT1—malignant glioma	0.000251	0.000483	CbGpPWpGaD
Levomilnacipran—ABCB1—HIF-1-alpha transcription factor network—VEGFA—malignant glioma	0.000248	0.000478	CbGpPWpGaD
Levomilnacipran—CYP3A4—Biological oxidations—PTGS1—malignant glioma	0.000236	0.000453	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism of lipids and lipoproteins—IDH1—malignant glioma	0.000235	0.000451	CbGpPWpGaD
Levomilnacipran—ABCB1—Integrated Pancreatic Cancer Pathway—PDGFRA—malignant glioma	0.000229	0.00044	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism of lipids and lipoproteins—SPHK1—malignant glioma	0.000227	0.000436	CbGpPWpGaD
Levomilnacipran—CYP2J2—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	0.000226	0.000434	CbGpPWpGaD
Levomilnacipran—CYP2J2—Metabolism—GSTP1—malignant glioma	0.000222	0.000428	CbGpPWpGaD
Levomilnacipran—CYP2J2—Metabolism—CAT—malignant glioma	0.000216	0.000416	CbGpPWpGaD
Levomilnacipran—ABCB1—Allograft Rejection—VEGFA—malignant glioma	0.000215	0.000414	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism of lipids and lipoproteins—IDH1—malignant glioma	0.000209	0.000403	CbGpPWpGaD
Levomilnacipran—ABCB1—Integrated Pancreatic Cancer Pathway—FGFR1—malignant glioma	0.000205	0.000393	CbGpPWpGaD
Levomilnacipran—CYP2J2—Metabolism—NCOR1—malignant glioma	0.000204	0.000393	CbGpPWpGaD
Levomilnacipran—SLC6A4—Circadian rythm related genes—TP53—malignant glioma	0.000203	0.000391	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism of lipids and lipoproteins—SPHK1—malignant glioma	0.000203	0.00039	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—COX8A—malignant glioma	0.000189	0.000363	CbGpPWpGaD
Levomilnacipran—ABCB1—Allograft Rejection—TNF—malignant glioma	0.000184	0.000354	CbGpPWpGaD
Levomilnacipran—ABCB1—Integrated Pancreatic Cancer Pathway—BAD—malignant glioma	0.000183	0.000352	CbGpPWpGaD
Levomilnacipran—ABCB1—Integrated Pancreatic Cancer Pathway—APC—malignant glioma	0.000177	0.000341	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—RTEL1—malignant glioma	0.000176	0.000339	CbGpPWpGaD
Levomilnacipran—ABCB1—Integrated Pancreatic Cancer Pathway—EGF—malignant glioma	0.000175	0.000337	CbGpPWpGaD
Levomilnacipran—CYP3A4—Biological oxidations—GSTP1—malignant glioma	0.000174	0.000335	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metapathway biotransformation—GSTP1—malignant glioma	0.000172	0.00033	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	0.000169	0.000324	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—COX8A—malignant glioma	0.000168	0.000324	CbGpPWpGaD
Levomilnacipran—CYP2J2—Metabolism—CAV1—malignant glioma	0.000167	0.00032	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—COX8A—malignant glioma	0.000164	0.000316	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—ASMT—malignant glioma	0.00016	0.000308	CbGpPWpGaD
Levomilnacipran—CYP2J2—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	0.000159	0.000306	CbGpPWpGaD
Levomilnacipran—ABCB1—HIF-1-alpha transcription factor network—AKT1—malignant glioma	0.000158	0.000305	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	0.000157	0.000301	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—COX8A—malignant glioma	0.000155	0.000298	CbGpPWpGaD
Levomilnacipran—CYP2J2—Metabolism—PIK3CG—malignant glioma	0.000152	0.000292	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—BCAN—malignant glioma	0.000151	0.00029	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	0.00015	0.000289	CbGpPWpGaD
Levomilnacipran—ABCB1—Integrated Pancreatic Cancer Pathway—FGF2—malignant glioma	0.000149	0.000287	CbGpPWpGaD
Levomilnacipran—CYP2J2—Metabolism—PPARG—malignant glioma	0.000146	0.000282	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—ASMT—malignant glioma	0.000143	0.000275	CbGpPWpGaD
Levomilnacipran—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—malignant glioma	0.000142	0.000273	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	0.00014	0.000269	CbGpPWpGaD
Levomilnacipran—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—malignant glioma	0.00014	0.000269	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—ASMT—malignant glioma	0.00014	0.000269	CbGpPWpGaD
Levomilnacipran—ABCB1—Transmembrane transport of small molecules—TFRC—malignant glioma	0.00014	0.000268	CbGpPWpGaD
Levomilnacipran—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—malignant glioma	0.000139	0.000268	CbGpPWpGaD
Levomilnacipran—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—malignant glioma	0.000138	0.000265	CbGpPWpGaD
Levomilnacipran—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—malignant glioma	0.000135	0.000259	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—BCAN—malignant glioma	0.000135	0.000259	CbGpPWpGaD
Levomilnacipran—CYP2J2—Metabolism—PIK3CD—malignant glioma	0.000133	0.000257	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—ASMT—malignant glioma	0.000132	0.000253	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—BCAN—malignant glioma	0.000131	0.000252	CbGpPWpGaD
Levomilnacipran—ABCB1—Transmembrane transport of small molecules—SLC5A5—malignant glioma	0.000128	0.000247	CbGpPWpGaD
Levomilnacipran—SLC6A2—Transmembrane transport of small molecules—RAF1—malignant glioma	0.000126	0.000241	CbGpPWpGaD
Levomilnacipran—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—malignant glioma	0.000125	0.000241	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—BCAN—malignant glioma	0.000124	0.000238	CbGpPWpGaD
Levomilnacipran—ABCB1—Transmembrane transport of small molecules—SLC6A3—malignant glioma	0.000122	0.000235	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—IDH2—malignant glioma	0.000121	0.000234	CbGpPWpGaD
Levomilnacipran—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—malignant glioma	0.000118	0.000226	CbGpPWpGaD
Levomilnacipran—CYP2J2—Metabolism—PIK3CB—malignant glioma	0.000116	0.000224	CbGpPWpGaD
Levomilnacipran—CYP2J2—Metabolism—PTGS2—malignant glioma	0.000115	0.000222	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	0.000115	0.00022	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—CYP2B6—malignant glioma	0.000114	0.00022	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—IDH2—malignant glioma	0.000108	0.000209	CbGpPWpGaD
Levomilnacipran—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—malignant glioma	0.000106	0.000204	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—IDH2—malignant glioma	0.000106	0.000204	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—IDH1—malignant glioma	0.000104	0.000201	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	0.000102	0.000197	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—CYP2B6—malignant glioma	0.000102	0.000196	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—COX8A—malignant glioma	0.000101	0.000195	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—SPHK1—malignant glioma	0.000101	0.000194	CbGpPWpGaD
Levomilnacipran—CYP2J2—Metabolism—PTEN—malignant glioma	0.0001	0.000193	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—IDH2—malignant glioma	9.97e-05	0.000192	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—CYP2B6—malignant glioma	9.95e-05	0.000191	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—CYP2C18—malignant glioma	9.9e-05	0.00019	CbGpPWpGaD
Levomilnacipran—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—malignant glioma	9.77e-05	0.000188	CbGpPWpGaD
Levomilnacipran—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—malignant glioma	9.55e-05	0.000184	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—CYP2B6—malignant glioma	9.38e-05	0.00018	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	9.34e-05	0.00018	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—IDH1—malignant glioma	9.33e-05	0.000179	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—IDH1—malignant glioma	9.1e-05	0.000175	CbGpPWpGaD
Levomilnacipran—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—malignant glioma	9.1e-05	0.000175	CbGpPWpGaD
Levomilnacipran—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—malignant glioma	9.02e-05	0.000174	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—SPHK1—malignant glioma	9.02e-05	0.000174	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—CYP2C18—malignant glioma	8.84e-05	0.00017	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—SPHK1—malignant glioma	8.81e-05	0.000169	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—CYP2C18—malignant glioma	8.63e-05	0.000166	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—ASMT—malignant glioma	8.6e-05	0.000165	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—IDH1—malignant glioma	8.58e-05	0.000165	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	8.51e-05	0.000164	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	8.34e-05	0.00016	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—SPHK1—malignant glioma	8.3e-05	0.00016	CbGpPWpGaD
Levomilnacipran—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—malignant glioma	8.29e-05	0.000159	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	8.21e-05	0.000158	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—CYP2C18—malignant glioma	8.13e-05	0.000156	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—BCAN—malignant glioma	8.09e-05	0.000156	CbGpPWpGaD
Levomilnacipran—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—malignant glioma	8.02e-05	0.000154	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—GSTT1—malignant glioma	8.01e-05	0.000154	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	7.59e-05	0.000146	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—PTGS1—malignant glioma	7.51e-05	0.000144	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	7.48e-05	0.000144	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	7.33e-05	0.000141	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—GSTT1—malignant glioma	7.15e-05	0.000137	CbGpPWpGaD
Levomilnacipran—CYP2J2—Metabolism—PIK3CA—malignant glioma	7.09e-05	0.000136	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—GSTT1—malignant glioma	6.98e-05	0.000134	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—BCHE—malignant glioma	6.98e-05	0.000134	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—SLC5A5—malignant glioma	6.89e-05	0.000133	CbGpPWpGaD
Levomilnacipran—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—malignant glioma	6.77e-05	0.00013	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—PTGS1—malignant glioma	6.7e-05	0.000129	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	6.68e-05	0.000128	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—GSTT1—malignant glioma	6.58e-05	0.000126	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—PTGS1—malignant glioma	6.54e-05	0.000126	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—IDH2—malignant glioma	6.52e-05	0.000125	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	6.52e-05	0.000125	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	6.46e-05	0.000124	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—BCHE—malignant glioma	6.23e-05	0.00012	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—PTGS1—malignant glioma	6.16e-05	0.000118	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—SLC5A5—malignant glioma	6.15e-05	0.000118	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—CYP2B6—malignant glioma	6.13e-05	0.000118	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—BCHE—malignant glioma	6.08e-05	0.000117	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—SLC5A5—malignant glioma	6e-05	0.000115	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	5.82e-05	0.000112	CbGpPWpGaD
Levomilnacipran—CYP2J2—Metabolism—AKT1—malignant glioma	5.79e-05	0.000111	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	5.76e-05	0.000111	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—BCHE—malignant glioma	5.73e-05	0.00011	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—SLC5A5—malignant glioma	5.66e-05	0.000109	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	5.63e-05	0.000108	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—IDH1—malignant glioma	5.61e-05	0.000108	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—GSTP1—malignant glioma	5.55e-05	0.000107	CbGpPWpGaD
Levomilnacipran—ABCB1—Transmembrane transport of small molecules—RAF1—malignant glioma	5.53e-05	0.000106	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—SPHK1—malignant glioma	5.43e-05	0.000104	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—CAT—malignant glioma	5.4e-05	0.000104	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—CYP2C18—malignant glioma	5.32e-05	0.000102	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—NCOR1—malignant glioma	5.1e-05	9.81e-05	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	5.03e-05	9.67e-05	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—GSTP1—malignant glioma	4.96e-05	9.53e-05	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—GSTP1—malignant glioma	4.84e-05	9.3e-05	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—CAT—malignant glioma	4.82e-05	9.27e-05	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—CAT—malignant glioma	4.71e-05	9.05e-05	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—GSTP1—malignant glioma	4.56e-05	8.76e-05	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—NCOR1—malignant glioma	4.55e-05	8.76e-05	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—NCOR1—malignant glioma	4.44e-05	8.55e-05	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—CAT—malignant glioma	4.44e-05	8.53e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—GSTT1—malignant glioma	4.3e-05	8.27e-05	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—NCOR1—malignant glioma	4.19e-05	8.05e-05	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—CAV1—malignant glioma	4.16e-05	8e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—PTGS1—malignant glioma	4.03e-05	7.75e-05	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	3.97e-05	7.64e-05	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—PIK3CG—malignant glioma	3.79e-05	7.28e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—BCHE—malignant glioma	3.75e-05	7.2e-05	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—CAV1—malignant glioma	3.71e-05	7.14e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—SLC5A5—malignant glioma	3.7e-05	7.11e-05	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—PPARG—malignant glioma	3.66e-05	7.03e-05	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—CAV1—malignant glioma	3.62e-05	6.97e-05	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	3.55e-05	6.82e-05	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—CAV1—malignant glioma	3.41e-05	6.57e-05	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—PIK3CG—malignant glioma	3.38e-05	6.5e-05	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—PIK3CD—malignant glioma	3.33e-05	6.4e-05	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—PIK3CG—malignant glioma	3.3e-05	6.35e-05	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—PPARG—malignant glioma	3.26e-05	6.28e-05	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—PPARG—malignant glioma	3.19e-05	6.13e-05	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—PIK3CG—malignant glioma	3.11e-05	5.98e-05	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—PPARG—malignant glioma	3e-05	5.77e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—GSTP1—malignant glioma	2.98e-05	5.73e-05	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—PIK3CD—malignant glioma	2.97e-05	5.72e-05	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—PIK3CB—malignant glioma	2.9e-05	5.58e-05	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—PIK3CD—malignant glioma	2.9e-05	5.58e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—CAT—malignant glioma	2.9e-05	5.58e-05	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—PTGS2—malignant glioma	2.88e-05	5.53e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—NCOR1—malignant glioma	2.74e-05	5.27e-05	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—PIK3CD—malignant glioma	2.73e-05	5.26e-05	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—PIK3CB—malignant glioma	2.59e-05	4.98e-05	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—PTGS2—malignant glioma	2.57e-05	4.94e-05	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—PIK3CB—malignant glioma	2.53e-05	4.86e-05	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—PTEN—malignant glioma	2.51e-05	4.82e-05	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—PTGS2—malignant glioma	2.51e-05	4.82e-05	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—PIK3CB—malignant glioma	2.38e-05	4.58e-05	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—PTGS2—malignant glioma	2.36e-05	4.54e-05	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—PTEN—malignant glioma	2.24e-05	4.31e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—CAV1—malignant glioma	2.23e-05	4.29e-05	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—PTEN—malignant glioma	2.19e-05	4.2e-05	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—PTEN—malignant glioma	2.06e-05	3.96e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—PIK3CG—malignant glioma	2.03e-05	3.91e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—PPARG—malignant glioma	1.96e-05	3.77e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—PIK3CD—malignant glioma	1.79e-05	3.44e-05	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—PIK3CA—malignant glioma	1.77e-05	3.4e-05	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—PIK3CA—malignant glioma	1.58e-05	3.04e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—PIK3CB—malignant glioma	1.56e-05	3e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—PTGS2—malignant glioma	1.54e-05	2.97e-05	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—PIK3CA—malignant glioma	1.54e-05	2.96e-05	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—PIK3CA—malignant glioma	1.45e-05	2.79e-05	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—AKT1—malignant glioma	1.45e-05	2.78e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—PTEN—malignant glioma	1.35e-05	2.59e-05	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—AKT1—malignant glioma	1.29e-05	2.48e-05	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—AKT1—malignant glioma	1.26e-05	2.42e-05	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—AKT1—malignant glioma	1.19e-05	2.28e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—PIK3CA—malignant glioma	9.5e-06	1.83e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—AKT1—malignant glioma	7.76e-06	1.49e-05	CbGpPWpGaD
